Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe?

Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2018, Vol 1, Issue 2

Abstract

Patients with liver cirrhosis are known to have increased risk of bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of thrombotic complications. Therefore, it is important to consider anticoagulation in cirrhotic patients. The purpose of this article is to review the epidemiological studies available in scientific literature comparing the risk of bleeding in cirrhotic patients utilizing DOACs vs traditional anticoagulation

Authors and Affiliations

Saad Qadwai, Tayyaba Rehman, Zeeshan Solangi

Keywords

Related Articles

The Burgeoning Role of the Gastrointestinal Microbiota

With the release of the landmark publication containing the information that there were more microorganisms in the gastrointestinal tract than any other cells [1] the scienti􀏐ic community began to look at the functional...

Asymptomatic Portal Cavernoma Revealing Activated Protein C Resistance

Introduction: Unlike the child, the portal cavernoma (PC) remains an exceptional and unusual complication of portal thrombosis in adults and the elderly. We report an original observation of asymptomatic PC secondary to...

The Role of Transabdominal Sonography in the Diagnostics of Choledocholithiasis: Compared to Endoscopic Retrograde Cholangiopancreatography

Common bile duct stone (CBDS) or choledocholithiasis (ChL) is one of the major pathologies that lead to serious complications, and accurate and early diagnosis is very important. ChL diagnostics is based on clinical, lab...

Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future

Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current...

Over View of Gastro Intestinal Diseases in UAE

One fifth of the population in UAE suffers from gastrointestinal diseases including obesity, reflux disease and fatty liver because of obesity, poor diets and close marriage, Acid reflux, ulcerative colitis and irritable...

Download PDF file
  • EP ID EP567577
  • DOI 10.32474/CTGH.2018.01.000106
  • Views 63
  • Downloads 0

How To Cite

Saad Qadwai, Tayyaba Rehman, Zeeshan Solangi (2018). Utilization of Direct Acting Oral Anticoagulants in Patients with Liver Cirrhosis: Is It Safe?. Current Trends in Gastroenterology and Hepatology, 1(2), 18-21. https://europub.co.uk./articles/-A-567577